Clinical trial · Observational
Quality of Life and Dysphagia Following Palliative Stenting in Esophageal Cancer
Quality of Life and Dysphagia Following Palliative Stenting in Esophageal Cancer (CT0023)
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Insuffisant personnel
Summary
Brief summary (as posted)
This study consists of a prospective clinical trial which aims to evaluate the impact of stent insertion for palliation of malignant dysphagia. The main goal being to examine the number of days required following stenting in order to have significant improvement in dysphagia and the length of time that this baseline is maintained. Approximately 100 patients will be prospectively enrolled in this study. Patients with end stage inoperable esophageal cancer deemed candidates for intraluminal esophageal palliative stent insertion will be prospectively enrolled into the study. Patients with esophageal obstruction or stricture due to other benign causes, tumors obstructing the cervical esophagus, as well as patients with airway-esophageal fistulas will be excluded from the study. The investigators plan to evaluate the efficacy of intra-esophageal stent insertion to improve malignant dysphagia as a main factor affecting the quality of life in these patients.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Esophageal Cancer | Malignant Esophageal Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- improvement of dysphagia post stenting
- timeFrame
- 3 months
- description
- To assess the effectiveness of esophageal stenting in improving malignant dysphagia and assess the time period relating to this improvement
Secondary outcomes (1)
- measure
- Quality of life post stenting
- timeFrame
- 3 months
- description
- To assess the effectiveness of esophageal stenting in improving quality of life and assess the time period relating to this improvement
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * All patients with end stage inoperable esophageal cancer deemed candidates for intraluminal esophageal palliative stent insertions. Exclusion Criteria: * Inability to consent for the study. * Patients less than 18 years old. * Patients with other benign causes of dysphagia and esophageal obstruction or stenosis. * Patients with malignant or benign airway - esophageal fistulas. * Patients with cervical esophageal cancer
References
Publications (0)
Data not yet available